CORALLABORATORIESLTD logo

Coral Laboratories Ltd

CORALLABORATORIESLTD·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap209.22 Cr
PE Ratio10.40
Volume—
Day High - Low—
52W High-Low679.00 - 360.00

Coral Laboratories Ltd (CORALLABORATORIESLTD): company summary

Coral Laboratories Ltd (CORALLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹209 crore operating in Pharmaceuticals on the NSE and BSE.

Coral Laboratories Ltd (CORALLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹209 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing steadily at 7.1% a year over three years; profit grew 39.8% a year, ahead of revenue — margins are expanding. Return on equity is 7.8%.
Valuation multiples
The stock trades at 10.4 times earnings, a discount to the Healthcare median of 32.0, 0.96 times book value. It yields 0.4%.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.0/10
Weak
Fair Value
Sign in to see
ROE
7.79%
Weak
P/E
10.40x
Cheap
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak

Price performance

52W₹360.00
₹679.00
DocStoX take

Supported by valuation (7.4), but held back by growth (2.2). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
5.0
/10
Weak
Quality
Solid
ROE 7.8%
Valuation
Fair
P/E 10.4×
Growth
Flat
Revenue -0.3% 5Y CAGR
Risk
Elevated
D/E 0.02
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹209 Cr
52W High / Low
₹679 / ₹360
Dividend Yield
0.36%
Promoter Holding
71.51%
EPS (TTM)
₹67.63
Book Value
₹585.74

Key highlights

  • Low leverage — D/E 0.02
  • Profitable in all of the last 5 years
  • Undemanding at 10× earnings
  • Revenue shrinking 0% a year
  • Growth is weak (2.2/10)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Coral Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.